Specific, rapid, and sensitive enzymatic measurement of sphingomyelin, phosphatidylcholine and lysophosphatidylcholine in serum and lipid extracts

Clinical Biochemistry

Volumn 41, Issue 14-15, 2008, Pages 1211-1217

  Hidaka, Hiroya ^a   Yamauchi, Kazuyoshi ^b   Ohta, Hiroyashi ^a   Akamatsu, Taiji ^b   Honda, Takayuki ^a   Katsuyama, Tsutomu ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Choline containing phospholipids; Enzymatic measurements; Lysophosphatidylcholine; Phosphatidylcholine; Phospholipids; Sphingomyelin

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN;

ACCURACY; ADULT; ANALYTIC METHOD; ANALYZER; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERUM;

BIOCHEMISTRY; CALIBRATION; HEALTH; HUMANS; HYDROLYSIS; LIPIDS; LIPOPROTEINS, HDL; LYSOPHOSPHATIDYLCHOLINES; MASS SPECTROMETRY; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASE D; REPRODUCIBILITY OF RESULTS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; SUBSTRATE SPECIFICITY; TISSUE EXTRACTS;

EID: 55649092868     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.06.010     Document Type: Article

References (29)

1. Nelson G.J. The phospholipid composition of plasma in various mammalian species. Lipids 2 (1967) 323-328
2. Wuthier R.E. Lipid composition of isolated epiphyseal cartilage cells, membranes and matrix vesicles. Biochim. Biophys. Acta 409 (1975) 128-143
3. Jendrasiak G.L., and Smith R.L. The effect of the choline head group on phospholipid hydration. Chem. Phys. Lipids 113 (2001) 55-66
4. Smith E.B. Intimal and medial lipids in human aorta. Lancet 1 (1960) 799-803
5. Schlitt A., Blankenberg S., Yan D., von Gizycki H., Buerke M., Werdan K., et al. Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutr. Metab. (Lond). 3 5 (2006) 1-8
6. Jiang X.C., Paultre F., Pearson T.A., Reed R.G., Francis C.K., Lin M., et al. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2614-2618
7. Noel C., Marcel Y.L., and Davignon J. Plasma phospholipids in the different types of primary hyperlipoproteinemia. J. Lab. Clin. Med. 79 (1972) 611-612
8. Jeong T., Schissel S.L., Tabas I., Pownall H.J., Tall A.R., and Jiang X. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J. Clin. Invest. 101 (1998) 905-912
9. Li Z., Basterr M.J., Hailemariam T.K., Hojjati M.R., Lu S., Liu J., et al. The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosis. Biochim. Biophys. Acta 1735 (2005) 130-134
10. Navab M., Berliner J.A., Subbanagounder G., Hama S., Lusis A.J., Castellani L.W., et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 481-488
11. Mahfouz M., and Kummerow F. Oxidized low density lipoprotein inhibits prostacyclin generation by rat aorta in vitro: a key role of lysolecithin. Prostaglandins Other Lipid Media.t 66 (2001) 283-304
12. Schissel S.L., Jiang X., Tweedie-Hardman J., Jeong T., Camejo E.H., Najib J., Rapp J.H., Williams K.J., and Tabas I. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. J. Biol. Chem. 273 (1998) 2738-2746
13. Holopainen J.M., Medina O.P., Metso A.J., and Kinnunen P.K. Sphingomyelinase activity associated with human plasma low density lipoprotein. J. Biol. Chem. 275 (2000) 16484-16489
14. Schneider P.B. Permanent sensitive stain for choline-containing phospholipids on thin-layer chromatograms. J. Lipid Res. 7 (1966) 169-170
15. Jungalwala F.B., Evans J.E., and McCluer R.H. High-performance liquid chromatography of phosphatidylcholine and sphingomyelin with detection in the region of 200 nm. Biochem. J. 155 (1976) 55-60
16. Phillips G.B., and Dodge J.T. Composition of phospholipids and of phospholipid fatty acids of human plasma. J. Lipid Res. 8 (1967) 676-681
17. Hidaka H., Hanyu N., Sugano M., Kawasaki K., Yamauchi K., and Katsuyama T. Analysis of human serum lipoprotein lipid composition using MALDI-TOF mass spectrometry. Ann. Clin. Lab. Sci. 37 (2007) 213-217
18. Blaton V., Buyzere M., Spincemaille J., and Declercq B. Enzymic assay for phosphatidyicholine and sphingomyelin in serum. Clin. Chem. 29 (1983) 806-809
19. McGowan M.W., Artlss J.D., and Zak B. Enzymatic colorimetry of lecithin and sphingomyelin in aqueous solution. Clin. Chem. 29 (1983) 1513-1517
20. Williams J.H., Kuchmak M., and Witter R.F. Quantitative determination of phospholipid classes in human serum by combined thin-layer chromatography and phosphorus analysis. Clin. Chim. Acta 25 (1969) 447-452
21. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234 (1959) 466-468
22. Rastegar A., Pelletier A., Duportail G., Freysz L., and Leray C. Sensitive analysis of phospholipid molecular species by high-performance liquid chromatography using fluorescent naproxen derivatives of diacylglycerols. J. Chromatogr. 518 (1990) 157-165
23. Sestak T.L., Subbaiah P.V., Jaskowiak N.T., and Bagdade J.D. A high-performance liquid chromatographic procedure for the determination of disaturated phosphatidylcholine in human plasma. Anal. Biochem. 191 (1990) 156-159
24. Steinbrecher U.P., and Pritchard P.H. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J. Lipid. Res. 30 (1989) 305-315
25. Hurt-Camejo E., Camejo G., Peilot H., Oorni K., and Kovanen P. Phospholipase A(2) in vascular disease. Circ. Res. 89 (2001) 298-304
26. McIntyre N., Harry D.S., and Pearson A.J. The hypercholesterolaemia of obstructive jaundice. Gut. 16 (1975) 379-391
27. Kajiyama G., Takata K., Horiuchi I., Nakagawa M., Yamamoto M., and Miyoshi A. Changes in high density lipoproteins in patients with hepatobiliary diseases. Levels and lipid composition of HDL2 and HDL3 and LCAT reaction. Gastroenterol. Jpn. 18 (1983) 98-108
28. Zeisel S.H. Choline phospholipids: signal transduction and carcinogenesis. FASEB. J. 7 (1993) 551-557
29. Schlitt A., Hojjati M.R., von Gizycki H., Lackner K.J., Blankenberg S., Schwaab B., et al. Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles. J. Lipid Res. 46 (2005) 196-200